Kymera Therapeutics(KYMR) - 2025 Q2 - Earnings Call Presentation

Kymera Therapeutics Second Quarter 2025 Quarterly Results Call August 11, 2025 Agenda Introduction Bruce Jacobs, CFA, MBA, Chief Financial Officer Key Highlights and Business Update Nello Mainolfi, PhD, Founder, President and Chief Executive Officer Clinical Update Jared Gollob, MD, Chief Medical Officer Financial Review Bruce Jacobs, CFA, MBA, Chief Financial Officer Question and Answer Session VISION EXECUTION IMPACT • Delivered 5 new investigational degrader drugs into the clinic since 2020, and on path ...